What is Cogent Biosciences, Inc.'s interest coverage?

Cogent Biosciences, Inc. (COGT) reported interest coverage of -84.7× in Q1 2026.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

Cogent Biosciences, Inc. COGT Interest coverage

Interest coverage at other companies

AmgenAMGN

3.9×+1.5×

IncyteINCY

689.3×+620×

Scholar RockSRRK

-55.5×+40.2×

BridgeBio PharmaBBIO

-7.1×-0.8×

Roivant SciencesROIV

122.5×+104×

BillionToOne, Inc. BLLN

582×—

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Enterprise value$5.68B+951%

P/S749.8×—

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Calculated from Cogent Biosciences, Inc.’s reported figures.

ebit/interest expense=-84.7×

Based on trailing twelve months.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s interest coverage?: Cogent Biosciences, Inc. (COGT) reported interest coverage of -84.7× in Q1 2026.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.